99Mo/99mTc separation: An assessment of technology options
Ashutosh Dash(Bhabha Atomic Research Centre), M.R.A. Pillai(Unknown), F. F. Knapp(Oak Ridge National Laboratory)
Cited by 88
Related Papers
Production of 177Lu for Targeted Radionuclide Therapy: Available Options
|Nuclear Medicine and Molecular Imaging|2015|375
Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives
|Frontiers in Medicine|2019|154
Sustained Availability of <sup>99m</sup>Tc: Possible Paths Forward
|Journal of Nuclear Medicine|2012|140
Peptide Receptor Radionuclide Therapy: An Overview
|Cancer Biotherapy and Radiopharmaceuticals|2015|122
Targeted Radionuclide Therapy - An Overview
|Current Radiopharmaceuticals|2013|117